Niemann-Pick Disease Type C: Clinical Trials

2 trials for Niemann-Pick Disease Type C, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Niemann-Pick Disease Type C: new trials by email Literature Review of Niemann-Pick Disease Type C trials Research Report on Niemann-Pick Disease Type C

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Safety and Tolerability of Nizubaglustat in Participants With Rare Lysosomal Disorders
AZ-3102 - Niemann-Pick Disease Type C, GM2 Gangliosidosis
Phase 2 / Phase 3Not yet recruitingAzafaros B.V.2182026-12-102026-10-21
Application of Miglustat in Patients With Niemann-Pick Type C
Miglustat - Niemann-Pick Disease Type C
Phase 3CompletedNational Taiwan University Hospital52008-01-012013-01-04

Narrower conditions

Niemann-Pick Disease, Type C (2)  ·  Gangliosidoses, GM2 (1)  ·  Gangliosidosis, GM1 (1)  ·  Gaucher Disease (1)

Broader conditions

Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Histiocytosis (2)  ·  Histiocytosis, Non-Langerhans-Cell (2)  ·  Lipid Metabolism Disorders (2)  ·  Lipid Metabolism, Inborn Errors (2)  ·  Lipidoses (2)  ·  Lymphatic Diseases (2)  ·  Lysosomal Storage Diseases (2)  ·  Lysosomal Storage Diseases, Nervous System (2)

Interventions

miglustat (1)

Sponsors

Azafaros B.V. (1)  ·  National Taiwan University Hospital (1)

Countries

Taiwan (1)

Top investigators

Whu-Liang Hwu, MD, PhD (1)

Results publications

PMID 22476655